OpenVSafe by OpenVAERS
Search V-safe

DU7-16705-18960

2 vaccinations 5 coded responses 11 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
280 / NC
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fever · Chills, Fatigue or tiredness
    Adult check-in
  5. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  9. 2021-01-27
    Survey response — day 14, dose 2
    MedDRA: Chills, Fatigue, Pain — Feeling: Fair
    Free text: Persistent fatigue, intermittent chills and bodyaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-17
    Survey response — day 35, dose 2
    MedDRA: Fatigue — Feeling: Fair
    Free text: Intermittent fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-14
    Survey response — 3 months, dose 2
    MedDRA: Dyspnoea exertional, Exercise tolerance decreased — Feeling: Good
    Free text: Since vaccination I have noticed a considerable decrease in exercise tolerance and shortness of breath upon exercise that was not present prior to vaccination. This was notable within 2-3 weeks of second dose when I first attempted to exercise.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-07-14
    Survey response — 6 months, dose 2
    MedDRA: Arthralgia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: multiple joint pains, mostly in the hands; also moderate to severe carpal tunnel syndrome
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2022-01-15
    Survey response — 12 months, dose 2
    MedDRA: Arthralgia, Grip strength decreased, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Following a few weeks after my second vaccine, I have had worsening joint pain in my hands, with significant weakness of my grip strength due to avoidance of grip (for instance it is very painful to write with pen/pencil due to right thumb pain)
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-13Pfizer-BioNTech

Free text

Release 2 — day 14, dose 2

2021-01-27

Symptoms: Persistent fatigue, intermittent chills and bodyaches

Release 4 — day 35, dose 2

2021-02-17

Symptoms: Intermittent fatigue

Release 7 — 3 months, dose 2

2021-04-14

Symptoms: Since vaccination I have noticed a considerable decrease in exercise tolerance and shortness of breath upon exercise that was not present prior to vaccination. This was notable within 2-3 weeks of second dose when I first attempted to exercise.

Release 9 — 6 months, dose 2

2021-07-14

Symptoms: multiple joint pains, mostly in the hands; also moderate to severe carpal tunnel syndrome

Release 10 — 12 months, dose 2

2022-01-15

Symptoms: Following a few weeks after my second vaccine, I have had worsening joint pain in my hands, with significant weakness of my grip strength due to avoidance of grip (for instance it is very painful to write with pen/pencil due to right thumb pain)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDChills ✓ ✓ ✓
SDDyspnoea exertional ✓ ✓ ✓
SDExercise tolerance decreased ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDGrip strength decreased · · ✓
SDPain ✓ ✓ ✓
SDPain in extremity · · ✓
SDPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release